Table 1.
Clinical parameters of participants in validation.
| Parameters | CHB with LGDHS | CHB with LKYDS | Ctrl |
|---|---|---|---|
| Individuals (n) | 32 | 21 | 21 |
| Male | 26 | 15 | 15 |
| Female | 5 | 6 | 6 |
| Age (years) | 37.9 ± 12.8 | 37.4 ± 13.7 | 35.23 ± 11.4 |
| ALT (IU/L) | 73.1 (10–412) | 82.8 (19–354) | 22.3 (14–43) |
| AST (IU/L) | 53.3 (25–207) | 60.0 (21–225) | 22.0 (16–49) |
| GGT (IU/L) | 53.5 (11–180) | 46.6 (16–285) | 20.8 (12–33) |
| ALP (IU/L) | 89.3 (51–185) | 84.6 (44–156) | 62.3 (42–96) |
| TBIL (μM/L) | 16.2 (7.6–38.5) | 17.4 (7.6–27.2) | 16.3 (6.9–27.1) |
| HBV DNA | 6079004 (0–94800000) | 6706693 (0–62270000) | 0 |
| HBV status (n) | |||
| HBsAg+ | 32 | 21 | 0 |
| HBsAg− | 0 | 0 | 21 |
Ages are given as mean ± S.D.; values of alanine aminotransferase (ALT), aspartate aminotransferase (AST), Gamma-glutamyltransferase (GGT), alkaline phosphatase (ALP), total bilirubin (TBIL) and HBV DNA were given as medians (range). LGDHS: liver-gallbladder dampness-heat syndrome; LKYDS: liver-kidney yin deficiency syndrome; Ctrl: healthy donor; HBsAg: hepatitis B surface antigen; HBV: hepatitis B virus.